Immunic, Inc. to Participate in Investor Conference in December
Press Releases
November 26, 2024

Immunic, Inc. to Participate in Investor Conference in December

NEW YORK, Nov. 26, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases,

bradford

The Bradford Era

Local & Social